Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Idan Levy

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cells|February 26, 2020
The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes MellitusSrinivas Pittala, Idan Levy, Soumasree De, et al.
Cells|October 15, 2024
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. <i>Cells</i> 2020, <i>9</i>, 481Srinivas Pittala, Idan Levy, Soumasree De, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2015
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel DiseasesBella Ungar, Idan Levy, Yarden Yavne, et al.
The Oncologist|September 24, 2020
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, et al.
Journal of Clinical Medicine|October 14, 2022
A Novel Prediction Tool for Endoscopic Intervention in Patients with Acute Upper Gastro-Intestinal BleedingIdo Veisman, Amit Oppenheim, Ronny Maman, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Surgical Endoscopy|July 16, 2024
Unsedated colonoscopy utilizing virtual reality distraction: a pilot-controlled studyIdo Veisman, Moran Tardio Duchan, Adi Lahat, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cells|February 26, 2020
The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes MellitusSrinivas Pittala, Idan Levy, Soumasree De, et al.
Cells|October 15, 2024
Correction: Pittala et al. The VDAC1-based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. <i>Cells</i> 2020, <i>9</i>, 481Srinivas Pittala, Idan Levy, Soumasree De, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2015
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel DiseasesBella Ungar, Idan Levy, Yarden Yavne, et al.
The Oncologist|September 24, 2020
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, et al.
Journal of Clinical Medicine|October 14, 2022
A Novel Prediction Tool for Endoscopic Intervention in Patients with Acute Upper Gastro-Intestinal BleedingIdo Veisman, Amit Oppenheim, Ronny Maman, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Surgical Endoscopy|July 16, 2024
Unsedated colonoscopy utilizing virtual reality distraction: a pilot-controlled studyIdo Veisman, Moran Tardio Duchan, Adi Lahat, et al.
Clinical and Translational Gastroenterology|March 17, 2022
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal AdenocarcinomaDoron Yablecovitch, Shomron Ben-Horin, Orit Picard, et al.
Cancer Medicine|September 12, 2024
Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinomaDoron Yablecovitch, Moshe Nadler, Shomron Ben-Horin, et al.
Pageof 2